Published in Cell Death Dis on March 23, 2017
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med (2003) 11.08
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol (2007) 8.31
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol (2004) 6.80
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med (2010) 4.90
The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev (2002) 3.28
Adoptive cell transfer as personalized immunotherapy for human cancer. Science (2015) 3.19
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med (2010) 2.91
Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist (2011) 2.89
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer (2012) 2.79
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res (2012) 2.43
Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology (2008) 2.08
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations. Nat Rev Drug Discov (2016) 1.34
T-cell exhaustion in the tumor microenvironment. Cell Death Dis (2015) 1.32
Immune-suppressive properties of the tumor microenvironment. Cancer Immunol Immunother (2013) 1.27
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res (2014) 1.17
Hyperthermia on immune regulation: a temperature's story. Cancer Lett (2008) 1.12
Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res (2013) 1.02
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model. J Transl Med (2006) 1.02
Myeloid-derived suppressor cells in malignant melanoma. J Dtsch Dermatol Ges (2014) 0.95
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol (2016) 0.92
Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine (2014) 0.92
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer (2007) 0.90
Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens. Crit Rev Immunol (2012) 0.87
Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model. Int J Hyperthermia (2009) 0.85
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology (2015) 0.85
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hyperthermia (2014) 0.84
Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia (2014) 0.83
Interleukin-6 Induced "Acute" Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics. Theranostics (2016) 0.83
Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in mice. Leukemia (2014) 0.83
MicroRNAs are implicated in the suppression of CD4+CD25− conventional T cell proliferation by CD4+CD25+ regulatory T cells. Mol Immunol (2015) 0.81
Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth. Cancer Lett (2013) 0.81
Design of microprobe for accurate thermal treatment of tumor. Cryo Letters (2011) 0.79
The future of biology in driving the field of hyperthermia. Int J Hyperthermia (2016) 0.79
Recent advances in thermal treatment techniques and thermally induced immune responses against cancer. IEEE Trans Biomed Eng (2014) 0.79
Design of a new probe for tumor treatment in the alternate thermal system based on numerical simulation. Conf Proc IEEE Eng Med Biol Soc (2011) 0.78
Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection. Immunobiology (2015) 0.77
Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation. Sci Rep (2016) 0.77
Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes. Drug Des Devel Ther (2015) 0.76